Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for Acne
NCT07366229Phase 2Recruiting
- Sponsor
- Shenzhen People's Hospital
- Start
- Dec 2025
- Primary completion
- Mar 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of MPN-coated engineered Lactobacillus reuteri cream in acne vulgaris, sponsored by Shenzhen People's Hospital. Started Dec 2025; status: recruiting.
02
Drugs
MPN-coated engineered Lactobacillus reuteri cream
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07366229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07366229.